Poly(ADP-ribose) polymerase inhibitors in the prevention of neuronal cell death

Bibliography

• SZABO C: Cell death: the role of PARR CRC Press, Boca Raton, Florida (2000).
   Google Scholar
• ZHANG J: PARP as a therapeutic target. CRC Press, Boca Raton, Florida (2001).
   Google Scholar
• LARNER AJ, SOFRONIEW MV: Mechanisms of cellular damage and recovery. In: Handbook of Neurological Rehabilitation (2nd edition). Greenwood RJ et al. (Eds), Churchill Livingstone, Edinburgh (2002). In Press.
   Google Scholar
• LARNER AJ: Alzheimer's disease: targets for drug development. Mini-Reviews in Medicinal Chemistry (2002) 2:1–9.
   PubMed Web of Science ®Google Scholar
• CHARRIAUT-MARLANGUE C, AGGOUN-ZOUAOUI D, REPRESA A, BEN-ART Y: Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci. (1996) 19:109–114.
   PubMed Web of Science ®Google Scholar
• CHOI DW: Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobial (1996) 8:667–672.
   Google Scholar
• SCHULZ JB, WELLER M, MOSKOWITZ MA: Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neural. (1999) 45:421–429.
   PubMed Web of Science ®Google Scholar
• HOLTZMAN DM, DESHMUKH M: Caspases: a treatment target for neurodegenerative disease? Nat. Med. (1997) 3:954–955.
   Web of Science ®Google Scholar
• YUAN J, YANKNER BA: Apoptosis in thenervous system. Nature (2000) 407:802–809.
   PubMed Web of Science ®Google Scholar
• LARNER AJ: Neuronal apoptosis as a therapeutic target in neurodegenerative disease. Expert Opin. Ther. Patents (2000) 10(10):1493–1518.
   Web of Science ®Google Scholar
• ASHRAFIAN H, DAVEY P: A review of the causes of central pontine myelinolysis: yet another apoptotic illness? Eur. 1. Neural (2001) 8:103–109.
   Web of Science ®Google Scholar
• NICHOLSON DW: From bench to clinic with apoptotic-based therapeutic agents. Nature (2000) 407:810–816.
   PubMed Web of Science ®Google Scholar
• ASHWELL S: Caspases: recent advances in small molecule inhibitors. Expert Opin. Ther. Patents (2001) 11(10):1593–1603.
   Web of Science ®Google Scholar
• •An interesting review of the development of caspase inhibitors.
   Google Scholar
• WYLLIE A, KERR JF, CURRIE AR: Cell death: the significance of apoptosis. mt. Rev Cytal (1980) 68:251–306.
   PubMedGoogle Scholar
• OPPENHEIM RW: Cell death during development of the nervous system. Ann. Rev Neurosci. (1991) 14:453–501.
   PubMed Web of Science ®Google Scholar
• HANNUN YA, BOUSTANY R-M (Eds). Apoptosis in neurobiology CRC Press, Boca Raton, Florida (1999).
   Google Scholar
• RENEHAN AG, BOOTH C, POTTEN CS: What is apoptosis and why is it important? Br Med. 1. (2001) 322:1536–1538.
   Google Scholar
• LOO DT, COPANI A, PIKE CJ, WHITTEMORE ER, WALENCEWICZ AJ, COTMAN CW: Apoptosis is induced by 3-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA (1993) 90:7951–7955.
   PubMed Web of Science ®Google Scholar
• LU DC, RABIZADEH S, CHANDRA S et al.: A second cytotoxic proteolytic peptide derived from amyloid 13-protein precursor. Nat. Med. (2000) 6:397–404.
   PubMed Web of Science ®Google Scholar
• WOLOZIN B, IWASAKI K, VITO P et al: Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (1996) 274: 1710-1713.
   Google Scholar
• CHUI D-H, TANAHASHI H, OZAWA K et al.: Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. (1999) 5:560–564.
   PubMed Web of Science ®Google Scholar
• CITRON M: The presenilins. In: Neurobiology of Alzheimer disease. Dawbarn D, Allen SJ (Eds.). Oxford University Press, Oxford, UK (2001):227–240.
   Google Scholar
• GIBSON RM: Does apoptosis have a role in neurodegeneration? Br Med. 1 (2001) 322:1539–1540.
   Google Scholar
• DE MURCIA G, SCHREIBER V, MOLINETE M et al.: Structure and function of poly(ADP-ribose) polymerase. Mal Cell Biachern. (1994) 138:15–24.
   PubMed Web of Science ®Google Scholar
• DE MURCIA G, MENISSIER-DE MURCIA J: Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biachern. Li. (1994) 14:172–176.
   Google Scholar
• D AMOURS D, DURIEZ PJ, ORTH K et al.: Purification of the death substrate poly(ADP-ribose) polymerase. Anal. Biachern. (1997) 249:106–108.
   PubMed Web of Science ®Google Scholar
• SHALL S, DE MURCIA G: Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat. Res. (2000) 460:1–15.
   Google Scholar
• LAZEBNIK YA, KAUFMANN SH, DESNOYERS S, POIRIER GG, EARNSHAW WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (1994) 371:346–347.
   PubMed Web of Science ®Google Scholar
• TEWARI M, QUAN LT, O'ROURKE K et al: YAMAJCPP3213, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell (1995) 81:801–809.
   PubMed Web of Science ®Google Scholar
• ZHANG J, DAWSON VL, DAWSON TM, SNYDER SH: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (1994) 263:687–689.
   PubMed Web of Science ®Google Scholar
• LO EH, BOSQUE-HAMILTON P, MENGW: Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation. Stroke (1998) 29:830–836.
   PubMed Web of Science ®Google Scholar
• NI B, WU X, DU Y etal.: Role of an ICE-related protease in KC1 deficiency-mediated and A13-induced neuronal death. In: Alzheimer's disease: biology, diagnosis and therapeutics. Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM (Eds), Wiley, Chichester (1997):485–490.
   Google Scholar
• STROSZNAJDER JB, JESKO H, STROSZNAJDER RP: Molecular mechanism of amyloid 13 peptides evoked alteration of DNA-bound poly(ADP-ribose) polymerase in adult and aged brain. Neurobiol. Aging (2000) 21 (Supp1.1):S253 (abstract 1155).
   Google Scholar
• ELIASSON MJL, SAMPEI K, MANDIR AS etal.: Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. (1997) 3:1089–1095.
   Google Scholar
• •The first PARP knockout showing protection against apoptosis.
   Google Scholar
• WHALEN MJ, CLARK RS, DIXON CE et al.: Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. Cereb. Blood Flow Metab. (1999) 19:835–842.
   PubMed Web of Science ®Google Scholar
• MANDIR AS, PRZEDBORSKI S, JACKSON LEWIS V etal.: Poly(ADP-ribose) polymerase activation mediates 1-methy1-4-pheny1-1,2,3,6-tetrahydro-pyridine (MPTP)-induced parkinsonism. Proc. Natl. Acad. Li. USA (1999) 96:5774–5779.
   Google Scholar
• MANDIR AS, POITRAS MF, BERLINERAR et al.: NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. j Neurosci. (2000) 20:8005–8011.
   PubMed Web of Science ®Google Scholar
• RUF A, DE MURCIA G, SCHULZ GE: Inhibitor and NAD± binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling. Biochemistry (1998) 37:3893–3900.
   PubMed Web of Science ®Google Scholar
• MABLEY JG, SUAREZ-PINZON WL, HASKO G et al.: Inhibition of poly(ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzpyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br. J. Pharmacol. (2001) 133:909–919.
   PubMed Web of Science ®Google Scholar
• SHAH GM, POIRIER D, DUCHAINE C et al.: Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo. Anal. Biochem. (1995) 227:1–13.
   PubMed Web of Science ®Google Scholar
• WANG Z-Q, STINGL L, MORRISON C et al.: PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. (1997) 11:2347–2358.
   PubMed Web of Science ®Google Scholar
• IRIZARRY MC, MCNAMARA M, FEDORCHAK K, HSIAO K, HYMAN BT: APP,,,transgenic mice develop age-related AP deposits and neuropil abnormalities but no neuronal loss in CAL Neuropath. Exp. Neural. (1997) 56:965–973.
   PubMed Web of Science ®Google Scholar
• IRIZARRY MC, SORIANO F, MCNAMARA M et al.: AP deposition is associated with neuropil changes but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. I Neurosci. (1997) 17:7053–7059.
   Google Scholar
• TONG WM, CORTES U, WANG ZQ: Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis. Biochem. Biophys. Acta (2001) 1552:27–37.
   PubMed Web of Science ®Google Scholar